L A Mandl1, K H Costenbader, J F Simard, E W Karlson. 1. Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York City, New York 10021, USA. MandlL@hss.edu
Abstract
OBJECTIVES: The "fetal origins of adult disease" hypothesis suggests the uterine environment can influence the susceptibility of a fetus to future disease. We examine whether the fetal environment, as reflected by birthweight, could modulate an individual's future risk of rheumatoid arthritis (RA). METHODS: The relationship between birthweight and the risk of incident RA was studied in 87 077 women followed prospectively in the Nurses' Health Study cohort. New cases of RA diagnosed between 1976 and 2002 were confirmed in 619 women. The association between birthweight and the future development of RA was studied in age-adjusted and Cox proportional hazard models adjusting for age and potential confounders, including history of maternal diabetes, childhood socioeconomic status, prematurity, maternal and paternal smoking, as well as additionally adjusting for risk factors for RA including smoking, age at menarche, use of oral contraceptives, use of post-menopausal hormones, total lifetime breastfeeding, and body mass index (BMI) at age 18. RESULTS: In an age-adjusted model, birthweight >4.54 kg vs birthweight 3.2-3.85 kg was associated with a two-fold increased risk of RA (relative risk (RR) = 2.1, 95% CI 1.4 to 3.3). Further adjusting for potential confounders and risk factors did not change this relationship (RR = 2.0, 95% CI 1.3 to 3.0). Findings were similar when we limited cases to those with rheumatoid factor positive RA (RR = 2.1, 95% CI = 1.2 to 3.6). CONCLUSIONS: In this large prospective cohort, birthweight >4.54 kg was associated with a two-fold increased risk of adult onset RA, compared with those of average birthweight. Further study of this observation may provide insight into the pathogenesis of RA.
OBJECTIVES: The "fetal origins of adult disease" hypothesis suggests the uterine environment can influence the susceptibility of a fetus to future disease. We examine whether the fetal environment, as reflected by birthweight, could modulate an individual's future risk of rheumatoid arthritis (RA). METHODS: The relationship between birthweight and the risk of incident RA was studied in 87 077 women followed prospectively in the Nurses' Health Study cohort. New cases of RA diagnosed between 1976 and 2002 were confirmed in 619 women. The association between birthweight and the future development of RA was studied in age-adjusted and Cox proportional hazard models adjusting for age and potential confounders, including history of maternal diabetes, childhood socioeconomic status, prematurity, maternal and paternal smoking, as well as additionally adjusting for risk factors for RA including smoking, age at menarche, use of oral contraceptives, use of post-menopausal hormones, total lifetime breastfeeding, and body mass index (BMI) at age 18. RESULTS: In an age-adjusted model, birthweight >4.54 kg vs birthweight 3.2-3.85 kg was associated with a two-fold increased risk of RA (relative risk (RR) = 2.1, 95% CI 1.4 to 3.3). Further adjusting for potential confounders and risk factors did not change this relationship (RR = 2.0, 95% CI 1.3 to 3.0). Findings were similar when we limited cases to those with rheumatoid factor positive RA (RR = 2.1, 95% CI = 1.2 to 3.6). CONCLUSIONS: In this large prospective cohort, birthweight >4.54 kg was associated with a two-fold increased risk of adult onset RA, compared with those of average birthweight. Further study of this observation may provide insight into the pathogenesis of RA.
Authors: Norbert Vaessen; Joop A Janssen; Peter Heutink; Albert Hofman; Steven W J Lamberts; Ben A Oostra; Huibert A P Pols; Cornelia M van Duijn Journal: Lancet Date: 2002-03-23 Impact factor: 79.321
Authors: J C Dekkers; R Geenen; G L Godaert; K A Glaudemans; F P Lafeber; L J van Doornen; J W Bijlsma Journal: J Rheumatol Date: 2001-07 Impact factor: 4.666
Authors: L J Vatten; B O Maehle; T I Lund Nilsen; S Tretli; C-c Hsieh; D Trichopoulos; S O Stuver Journal: Br J Cancer Date: 2002-01-07 Impact factor: 7.640
Authors: Hamed Khalili; Ashwin N Ananthakrishnan; Leslie M Higuchi; James M Richter; Charles S Fuchs; Andrew T Chan Journal: Inflamm Bowel Dis Date: 2013-03 Impact factor: 5.325
Authors: Julia F Simard; Karen H Costenbader; Miguel A Hernán; Matthew H Liang; Murray A Mittleman; Elizabeth W Karlson Journal: J Rheumatol Date: 2009-10-15 Impact factor: 4.666
Authors: Anders J Svendsen; Kirsten O Kyvik; Gunnar Houen; Christian Nielsen; René Holst; Axel Skytthe; Peter Junker Journal: Rheumatol Int Date: 2013-11-05 Impact factor: 2.631
Authors: Yvonne C Lee; Jessica Agnew-Blais; Susan Malspeis; Katherine Keyes; Karen Costenbader; Laura D Kubzansky; Andrea L Roberts; Karestan C Koenen; Elizabeth W Karlson Journal: Arthritis Care Res (Hoboken) Date: 2016-03 Impact factor: 4.794
Authors: Christine G Parks; Aimee A D'Aloisio; Lisa A DeRoo; Kirstin Huiber; Lisa G Rider; Frederick W Miller; Dale P Sandler Journal: Ann Rheum Dis Date: 2012-05-14 Impact factor: 19.103